SOAT1 and ovarian carcinoma: This review highlights the current knowledge of STAT biology in ovarian cancer, with an emphasis on epithelial ovarian cancer, while also providing a comprehensive discussion on STAT specific inhibitors in preclinical and clinical stages of development.